Condition: Delirium · Sponsor: Sultan Qaboos University
The high prevalence of delirium in hospitalized older adults, with significant associated morbidity and mortality, emphasize the need for effective prevention strategies. Limited trials have explored melatonin's potential in preventing delirium among patients admitted to general medical wards. Previous trials on melatonin's preventive role in medical wards had limitations, necessitating a robust, double-blinded, placebo-controlled design with a larger sample size. This randomized, double-blind study of melatonin versus placebo aims to investigate the efficacy of melatonin, a neurohormone regulating the sleep-wake cycle, in preventing delirium among medically hospitalized patients aged 65 or older. Given the high prevalence of delirium in this population and its association with adverse outcomes, the study seeks to contribute valuable insights into an effective preventive strategy.
This description comes directly from the study's public registry record.
Abdullah M Al Alawi, FRACP · +96895384990 · dr.abdullahalalawi@gmail.com
Juhaina Salim Al Maqbali, MSc · juhaina@squ.edu.om
Always discuss trial participation with your own doctor first.
| Sultan Qaboos University Hospital | Muscat, Oman | Not Yet Recruiting |
| Sultan Qaboos University Hospital | Muscat, Oman | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06509191